Enanta Pharmaceuticals Inc [NASDAQ: ENTA] traded at a high on Thursday, posting a 3.45 gain after which it closed the day’ session at $5.10.
The results of the trading session contributed to over 183462 shares changing hands. Over the past one week, the price volatility of Enanta Pharmaceuticals Inc stands at 10.28% while the volatility over the past one month is 8.47%.
The market cap for ENTA stock reached $108.80 million, with 21.33 million shares outstanding and 19.82 million shares in the current float. Compared to the average trading volume of 370.53K shares, ENTA reached a trading volume of 183462 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Enanta Pharmaceuticals Inc [ENTA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENTA shares is $15.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENTA stock is a recommendation set at 2.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Enanta Pharmaceuticals Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on August 09, 2023. While these analysts kept the previous recommendation, Jefferies dropped their target price from $49 to $18. The new note on the price target was released on August 08, 2023, representing the official price target for Enanta Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $56, while H.C. Wainwright analysts kept a Buy rating on ENTA stock.
The Average True Range (ATR) for Enanta Pharmaceuticals Inc is set at 0.47, with the Price to Sales ratio for ENTA stock in the period of the last 12 months amounting to 1.63. The Price to Book ratio for the last quarter was 0.97, with the Price to Cash per share for the same quarter was set at 10.19.
How has ENTA stock performed recently?
Enanta Pharmaceuticals Inc [ENTA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.72. With this latest performance, ENTA shares dropped by -20.81% in over the last four-week period, additionally sinking by -56.30% over the last 6 months – not to mention a drop of -66.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENTA stock in for the last two-week period is set at 43.45, with the RSI for the last a single of trading hit 48.17, and the three-weeks RSI is set at 42.49 for Enanta Pharmaceuticals Inc [ENTA]. The present Moving Average for the last 50 days of trading for this stock 6.28, while it was recorded at 4.96 for the last single week of trading, and 9.36 for the last 200 days.
Enanta Pharmaceuticals Inc [ENTA]: Deeper insight into the fundamentals
Enanta Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.47 and a Current Ratio set at 5.47.
Earnings analysis for Enanta Pharmaceuticals Inc [ENTA]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ENTA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Enanta Pharmaceuticals Inc go to 6.25%.
Insider trade positions for Enanta Pharmaceuticals Inc [ENTA]
There are presently around $95.67%, or 102.41%% of ENTA stock, in the hands of institutional investors. The top three institutional holders of ENTA stocks are: FARALLON CAPITAL MANAGEMENT LLC with ownership of 2.1 million shares, which is approximately 9.8914%. VANGUARD GROUP INC, holding 1.93 million shares of the stock with an approximate value of $$25.09 million in ENTA stocks shares; and VANGUARD GROUP INC, currently with $$23.96 million in ENTA stock with ownership which is approximately 8.7229%.
